Who owns the BUPREXONE trademark?

The BUPREXONE trademark is owned by Matthew 7:25 Inc..

What class is the BUPREXONE trademark registered in?

The BUPREXONE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for BUPREXONE?

The USPTO serial number for BUPREXONE is 87917143.

What is the registration number for BUPREXONE?

BUPREXONE is registered under USPTO registration number 5829816.

Sealvo

Home Search: BUPREXONEBUPREXONE #87917143

Back

Updated Sep 17, 2026·28 searches this week

View on USPTO TSDR Find similar marks

BUP

USPTO Trademark Record

REGISTERED

BUPREXONE

SN 87917143·Reg 5829816·Filed May 11, 2018

Owner Matthew 7:25 Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

BUPREXONE (Serial No. 87917143), Registration No. 5829816, is a registered US trademark filed on May 11, 2018 by Matthew 7:25 Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Section 8/9 declaration window: August 06, 2029

Conflict Analysis

Full conflict analysis for BUPREXONE (SN 87917143) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

BUPREXONE (Reg. #5829816) is a registered US trademark that has been protecting its owner, Matthew 7:25 Inc., since 2018. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 11, 2018

SERIAL

87917143

REG#

5829816

REGISTERED

Aug 06, 2019

Filing Information

StatusREGISTERED

Filing DateMay 11, 2018

Serial Number87917143

Registration No.5829816

Registration DateAug 06, 2019

Status DateJan 12, 2026

Published for OppositionOct 23, 2018

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlySection 8 AcceptedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Feb 07, 2019

First use in commerce: Feb 07, 2019

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

30 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jan 12, 2026

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED

Jan 12, 2026

REGISTERED - SEC. 8 (6-YR) ACCEPTED

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Jan 12, 2026

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

TEAS SECTION 8 RECEIVED

Sep 02, 2025

TEAS SECTION 8 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Aug 06, 2024

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Aug 06, 2019

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jun 29, 2019

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jun 28, 2019

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 22, 2019

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 21, 2019

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 1 GRANTED

Jun 21, 2019

SOU EXTENSION 1 GRANTED

STATEMENT OF USE PROCESSING COMPLETE

Jun 21, 2019

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Jun 18, 2019

TEAS STATEMENT OF USE RECEIVED

SOU TEAS EXTENSION RECEIVED

Jun 18, 2019

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jun 18, 2019

SOU EXTENSION 1 FILED

USE AMENDMENT FILED

Jun 18, 2019

USE AMENDMENT FILED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 08, 2019

TEAS CHANGE OF CORRESPONDENCE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 18, 2018

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Oct 23, 2018

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 23, 2018

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 03, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Sep 20, 2018

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Sep 17, 2018

ASSIGNED TO LIE

EXAMINERS AMENDMENT -WRITTEN

Sep 05, 2018

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Sep 05, 2018

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 05, 2018

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Sep 05, 2018

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 05, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Sep 04, 2018

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 19, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by Matthew 7:25 Inc.

Additional USPTO filings from the same owner.

CAF

CAFFEINE MELT

88334528

MATTHEW 7:25, INC.

REGISTERED

ALT

ALTREXONE

87917692

Matthew 7:25 Inc.

ABANDONED

ODA

ODATS

87917710

Matthew 7:25 Inc.

ABANDONED

BUPREXONE

Run a conflict check

Other Marks by Matthew 7:25 Inc.

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company